Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02107170
Other study ID # VIAEV
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date February 2014
Est. completion date December 2017

Study information

Verified date June 2018
Source First Affiliated Hospital, Sun Yat-Sen University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Endovascular repair of aortic aneurysm and endovascular treatment of arteriosclerosis obliterans of lower extremities are two kinds of common surgeries in the investigators' hospital. The effects of anesthetic agents on postoperative outcome, especially cognitive function, are not clear. In this study investigators propose to measure postoperative cognitive function and other outcome of patients who are undergoing these two kinds of surgeries, and try to identify whether there is an association between different kinds of anesthetics and postoperative outcome. Investigators will also observe whether changes in plasma levels of VEGF, TGF-1, TNF-α, IL-1β, and IL-6, are associated with postoperative delirium or cognitive change.


Recruitment information / eligibility

Status Completed
Enrollment 68
Est. completion date December 2017
Est. primary completion date October 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years to 100 Years
Eligibility Inclusion Criteria:

- age 18-100 years of age

- Patients presenting for Endovascular repair of aortic aneurysm and endovascular treatment of arteriosclerosis obliterans of lower extremities

Exclusion Criteria:

- Patients with pre-existing delirium

- Inablility to converse

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Sevoflurane
sevoflurane-based general anesthesia
Propofol
total intravenous anesthesia
Remifentanil


Locations

Country Name City State
China First Affiliated Hospital, Sun Yat-Sen University Guangzhou Guangdong

Sponsors (1)

Lead Sponsor Collaborator
Tao Zhang

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of patients with postoperative cognitive dysfunction 7 days after surgery
Secondary Number of patients with postoperative cognitive dysfunction 3 months after surgery
Secondary Changes in plasma levels of VEGF, TGF-1, TNF-a, IL-1ß, and IL-6 (a composite outcome measure) 3 days after surgery